IDrugs | Most viewed articles in past 30 days

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Quick Search

	IDrugs
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

IDrugs

Home

Advanced search

Archive

Current Opinion journals

About this journal

Most viewed

Article alerts

IDrugs: Most viewed articles in past 30 days

[more info]

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, over the last 30 days. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles in the past year and all time most-viewed articles are also available

most viewed articles over the last 30 days from all BioMed Central Journals

1. Accesses 73	Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus J Calado IDrugs 2009, 12:785-798 (23November2009) [Abstract] [Full text] [PDF]
2. Accesses 45	Interscience Conference on Antimicrobial Agents and Chemotherapy - 49th Annual Meeting. Part 1 B Turner, L Murch IDrugs 2009, 12:667-669 (19October2009) [Abstract] [Full text] [PDF]
3. Accesses 39	The challenges of immunogenicity in developing biosimilar products M Wadhwa, R Thorpe IDrugs 2009, 12:440-444 (30June2009) [Abstract] [Full text] [PDF]
4. Accesses 39	Current trends in the clinical development of peptide therapeutics PM Saladin, BD Zhang, JM Reichert IDrugs 2009, 12:779-784 (23November2009) [Abstract] [Full text] [PDF]
5. Accesses 39	Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling EM Lewiecki IDrugs 2009, 12:799-809 (23November2009) [Abstract] [Full text] [PDF]
6. Accesses 37	Bacterial adhesion - A source of alternate antibiotic targets CK Cusumano, SJ Hultgren IDrugs 2009, 12:699-705 (19October2009) [Abstract] [Full text] [PDF]
7. Accesses 37	Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS disorders and pain A Al-Shamahi, K Kirkham, L Hookes IDrugs 2009, 12:731-733 (23November2009) [Abstract] [Full text] [PDF]
8. Accesses 34	Erratum - Drug evaluation: Deferitrin (GT-56-252; NaHBED) for iron overload disorders JC Barton IDrugs 2007, 10:480-490 (6July2007) [Abstract] [Full text] [PDF] [PubMed] [Related articles]
9. Accesses 33	Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease RF Riley, MA Corson IDrugs 2009, 12:648-655 (24September2009) [Abstract] [Full text] [PDF]
10. Accesses 31	The role of mitochondrial dysfunction and drug safety S Nadanaciva, Y Will IDrugs 2009, 12:706-710 (19October2009) [Abstract] [Full text] [PDF]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us